ID   MK08_RAT                Reviewed;         411 AA.
AC   P49185;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   02-OCT-2024, entry version 205.
DE   RecName: Full=Mitogen-activated protein kinase 8;
DE            Short=MAP kinase 8;
DE            Short=MAPK 8;
DE            EC=2.7.11.24 {ECO:0000269|PubMed:11121042, ECO:0000269|PubMed:16618812, ECO:0000269|PubMed:21297631, ECO:0000269|PubMed:9516415};
DE   AltName: Full=SAPK gamma;
DE   AltName: Full=Stress-activated protein kinase JNK1;
DE   AltName: Full=c-Jun N-terminal kinase 1;
DE   AltName: Full=p54 gamma;
GN   Name=Mapk8; Synonyms=Jnk1, Prkm8;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8177321; DOI=10.1038/369156a0;
RA   Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F.,
RA   Avruch J., Woodgett J.R.;
RT   "The stress-activated protein kinase subfamily of c-Jun kinases.";
RL   Nature 369:156-160(1994).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RC   TISSUE=Heart;
RX   PubMed=9516415; DOI=10.1074/jbc.273.13.7228;
RA   Clerk A., Fuller S.J., Michael A., Sugden P.H.;
RT   "Stimulation of 'stress-regulated' mitogen-activated protein kinases
RT   (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-
RT   activated protein kinases) in perfused rat hearts by oxidative and other
RT   stresses.";
RL   J. Biol. Chem. 273:7228-7234(1998).
RN   [3]
RP   CATALYTIC ACTIVITY, S-NITROSYLATION AT CYS-116, AND MUTAGENESIS OF CYS-116.
RX   PubMed=11121042; DOI=10.1073/pnas.97.26.14382;
RA   Park H.S., Huh S.H., Kim M.S., Lee S.H., Choi E.J.;
RT   "Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated
RT   protein kinase by means of S-nitrosylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14382-14387(2000).
RN   [4]
RP   IDENTIFICATION IN A COMPLEX WITH MAPK8IP1 AND ARHGEF28.
RX   PubMed=14499478; DOI=10.1016/s0169-328x(03)00263-8;
RA   Wu J., Zhai J., Lin H., Nie Z., Ge W.-W., Garcia-Bermejo L., Muschel R.J.,
RA   Schlaepfer W.W., Canete-Soler R.;
RT   "Cytoplasmic retention sites in p190RhoGEF confer anti-apoptotic activity
RT   to an EGFP-tagged protein.";
RL   Brain Res. Mol. Brain Res. 117:27-38(2003).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH MAPK8IP1; STMN2; STMN3 AND
RP   STMN4, AND SUBCELLULAR LOCATION.
RX   PubMed=16618812; DOI=10.1083/jcb.200511055;
RA   Tararuk T., Ostman N., Li W., Bjorkblom B., Padzik A., Zdrojewska J.,
RA   Hongisto V., Herdegen T., Konopka W., Courtney M.J., Coffey E.T.;
RT   "JNK1 phosphorylation of SCG10 determines microtubule dynamics and
RT   axodendritic length.";
RL   J. Cell Biol. 173:265-277(2006).
RN   [6]
RP   INTERACTION WITH GRIPAP1.
RX   PubMed=17761173; DOI=10.1016/j.febslet.2007.08.008;
RA   Ye B., Yu W.P., Thomas G.M., Huganir R.L.;
RT   "GRASP-1 is a neuronal scaffold protein for the JNK signaling pathway.";
RL   FEBS Lett. 581:4403-4410(2007).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=21297631; DOI=10.1038/nn.2755;
RA   Westerlund N., Zdrojewska J., Padzik A., Komulainen E., Bjorkblom B.,
RA   Rannikko E., Tararuk T., Garcia-Frigola C., Sandholm J., Nguyen L.,
RA   Kallunki T., Courtney M.J., Coffey E.T.;
RT   "Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and
RT   neuronal migration rate.";
RL   Nat. Neurosci. 14:305-313(2011).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=29166604; DOI=10.1016/j.celrep.2017.10.084;
RA   Bharat V., Siebrecht M., Burk K., Ahmed S., Reissner C.,
RA   Kohansal-Nodehi M., Steubler V., Zweckstetter M., Ting J.T., Dean C.;
RT   "Capture of Dense Core Vesicles at Synapses by JNK-Dependent
RT   Phosphorylation of Synaptotagmin-4.";
RL   Cell Rep. 21:2118-2133(2017).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various processes
CC       such as cell proliferation, differentiation, migration, transformation
CC       and programmed cell death (PubMed:16618812, PubMed:9516415).
CC       Extracellular stimuli such as pro-inflammatory cytokines or physical
CC       stress stimulate the stress-activated protein kinase/c-Jun N-terminal
CC       kinase (SAP/JNK) signaling pathway. In this cascade, two dual
CC       specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and
CC       activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of
CC       transcription factors, primarily components of AP-1 such as JUN, JDP2
CC       and ATF2 and thus regulates AP-1 transcriptional activity.
CC       Phosphorylates the replication licensing factor CDT1, inhibiting the
CC       interaction between CDT1 and the histone H4 acetylase HBO1 to
CC       replication origins. Loss of this interaction abrogates the acetylation
CC       required for replication initiation. Promotes stressed cell apoptosis
CC       by phosphorylating key regulatory factors including p53/TP53 and Yes-
CC       associates protein YAP1. In T-cells, MAPK8 and MAPK9 are required for
CC       polarized differentiation of T-helper cells into Th1 cells. Contributes
CC       to the survival of erythroid cells by phosphorylating the antagonist of
CC       cell death BAD upon EPO stimulation. Mediates starvation-induced BCL2
CC       phosphorylation, BCL2 dissociation from BECN1, and thus activation of
CC       autophagy. Phosphorylates STMN2 and hence regulates microtubule
CC       dynamics, controlling neurite elongation in cortical neurons. In the
CC       developing brain, through its cytoplasmic activity on STMN2, negatively
CC       regulates the rate of exit from multipolar stage and of radial
CC       migration from the ventricular zone (PubMed:21297631). Phosphorylates
CC       several other substrates including heat shock factor protein 4 (HSF4),
CC       the deacetylase SIRT1, ELK1, or the E3 ligase ITCH. Phosphorylates the
CC       CLOCK-BMAL1 heterodimer and plays a role in the regulation of the
CC       circadian clock (By similarity). Phosphorylates the heat shock
CC       transcription factor HSF1, suppressing HSF1-induced transcriptional
CC       activity (By similarity). Phosphorylates POU5F1, which results in the
CC       inhibition of POU5F1's transcriptional activity and enhances its
CC       proteasomal degradation (By similarity). Phosphorylates JUND and this
CC       phosphorylation is inhibited in the presence of MEN1 (By similarity).
CC       In neurons, phosphorylates SYT4 which captures neuronal dense core
CC       vesicles at synapses (PubMed:29166604). Phosphorylates EIF4ENIF1/4-ET
CC       in response to oxidative stress, promoting P-body assembly (By
CC       similarity). Phosphorylates SIRT6 in response to oxidative stress,
CC       stimulating its mono-ADP-ribosyltransferase activity (By similarity).
CC       Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (By
CC       similarity). Phosphorylates ALKBH5 in response to reactive oxygen
CC       species (ROS), promoting ALKBH5 sumoylation and inactivation (By
CC       similarity). {ECO:0000250|UniProtKB:P45983,
CC       ECO:0000250|UniProtKB:Q91Y86, ECO:0000269|PubMed:16618812,
CC       ECO:0000269|PubMed:21297631, ECO:0000269|PubMed:29166604,
CC       ECO:0000269|PubMed:9516415}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24;
CC         Evidence={ECO:0000269|PubMed:11121042, ECO:0000269|PubMed:16618812,
CC         ECO:0000269|PubMed:21297631, ECO:0000269|PubMed:9516415};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.24; Evidence={ECO:0000269|PubMed:11121042,
CC         ECO:0000269|PubMed:16618812, ECO:0000269|PubMed:21297631,
CC         ECO:0000269|PubMed:9516415};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:9516415};
CC   -!- ACTIVITY REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by either of two dual specificity kinases, MAP2K4 and
CC       MAP2K7. MAP2K4 shows a strong preference for Tyr-185 while MAP2K7
CC       phosphorylates Tyr-183 preferentially. Inhibited by dual specificity
CC       phosphatases, such as DUSP1. Inhibited by SERPINB3 (By similarity).
CC       Inhibited by IFN-gamma-induced S-nitrosylation.
CC       {ECO:0000250|UniProtKB:P45983}.
CC   -!- SUBUNIT: Forms a complex with MAPK8IP1 and ARHGEF28 (PubMed:14499478).
CC       Found in a complex with SH3RF1, RAC1, MAP3K11/MLK3, MAP2K7/MKK7 and
CC       MAPK8IP1/JIP1. Found in a complex with SH3RF1, RAC2, MAP3K7/TAK1,
CC       MAP2K7/MKK7, MAPK8IP1/JIP1 and MAPK9/JNK2 (By similarity). Binds to at
CC       least four scaffolding proteins, MAPK8IP1/JIP-1, MAPK8IP2/JIP-2,
CC       MAPK8IP3/JIP-3/JSAP1 and SPAG9/MAPK8IP4/JIP-4. These proteins also bind
CC       other components of the JNK signaling pathway. Interacts with TP53,
CC       WWOX. Interacts with JAMP. Interacts with NFATC4. Interacts
CC       (phosphorylated form) with NFE2; the interaction phosphorylates NFE2 in
CC       undifferentiated cells. Interacts with MECOM; regulates JNK signaling.
CC       Interacts with PIN1; this interaction mediates MAPK8 conformational
CC       changes leading to the binding of MAPK8 to its substrates (By
CC       similarity). Interacts with HSF1 (via D domain and preferentially with
CC       hyperphosphorylated form); this interaction occurs under both normal
CC       growth conditions and immediately upon heat shock (By similarity).
CC       Interacts with STMN2, STMN3 and STMN4 (PubMed:16618812). Interacts with
CC       GRIPAP1 (PubMed:17761173). Interacts with POU5F1; phosphorylates POU5F1
CC       at 'Ser-347'. Interacts with HSF4 (By similarity).
CC       {ECO:0000250|UniProtKB:P45983, ECO:0000250|UniProtKB:Q91Y86,
CC       ECO:0000269|PubMed:14499478, ECO:0000269|PubMed:16618812,
CC       ECO:0000269|PubMed:17761173}.
CC   -!- INTERACTION:
CC       P49185; P19491-3: Gria2; NbExp=2; IntAct=EBI-7456505, EBI-9118256;
CC       P49185; P19493: Gria4; NbExp=2; IntAct=EBI-7456505, EBI-7761834;
CC       P49185; P17325: Jun; NbExp=2; IntAct=EBI-7456505, EBI-7709365;
CC       P49185; P50232: Syt4; NbExp=5; IntAct=EBI-7456505, EBI-540118;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16618812}. Nucleus
CC       {ECO:0000250|UniProtKB:Q91Y86}. Synapse {ECO:0000269|PubMed:29166604}.
CC       Note=In the cortical neurons, predominantly cytoplasmic and associated
CC       with the Golgi apparatus and endosomal fraction (PubMed:16618812).
CC       Increased neuronal activity increases phosphorylated form at synapses
CC       (PubMed:29166604). Colocalizes with POU5F1 in the nucleus (By
CC       similarity). {ECO:0000250|UniProtKB:Q91Y86,
CC       ECO:0000269|PubMed:16618812, ECO:0000269|PubMed:29166604}.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-183 and Tyr-185 by MAP2K7 and MAP2K4,
CC       which activates the enzyme. Phosphorylated by TAOK2 (By similarity).
CC       Phosphorylated form is more concentrated at synapses than none-
CC       phosphorylated (PubMed:29166604). {ECO:0000250,
CC       ECO:0000269|PubMed:29166604}.
CC   -!- PTM: Nitrosylated upon IFN-gamma-induced endogenous NO production,
CC       which inhibits the enzyme (PubMed:11121042). May be phosphorylated at
CC       Thr-183 and Tyr-185 by MAP3K1/MEKK1 (By similarity).
CC       {ECO:0000250|UniProtKB:P45983, ECO:0000269|PubMed:11121042}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. MAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27129; AAA42111.1; -; mRNA.
DR   PIR; S43970; S43970.
DR   RefSeq; NP_446281.2; NM_053829.2.
DR   AlphaFoldDB; P49185; -.
DR   SMR; P49185; -.
DR   IntAct; P49185; 6.
DR   MINT; P49185; -.
DR   STRING; 10116.ENSRNOP00000062048; -.
DR   BindingDB; P49185; -.
DR   ChEMBL; CHEMBL5718; -.
DR   GlyGen; P49185; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P49185; -.
DR   PhosphoSitePlus; P49185; -.
DR   jPOST; P49185; -.
DR   PaxDb; 10116-ENSRNOP00000062048; -.
DR   GeneID; 116554; -.
DR   KEGG; rno:116554; -.
DR   UCSC; RGD:621506; rat.
DR   AGR; RGD:621506; -.
DR   CTD; 5599; -.
DR   RGD; 621506; Mapk8.
DR   eggNOG; KOG0665; Eukaryota.
DR   InParanoid; P49185; -.
DR   OrthoDB; 158564at2759; -.
DR   PhylomeDB; P49185; -.
DR   BRENDA; 2.7.11.24; 5301.
DR   Reactome; R-RNO-111446; Activation of BIM and translocation to mitochondria.
DR   Reactome; R-RNO-139910; Activation of BMF and translocation to mitochondria.
DR   Reactome; R-RNO-193648; NRAGE signals death through JNK.
DR   Reactome; R-RNO-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-RNO-450341; Activation of the AP-1 family of transcription factors.
DR   Reactome; R-RNO-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-RNO-9007892; Interleukin-38 signaling.
DR   PRO; PR:P49185; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0097441; C:basal dendrite; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0032839; C:dendrite cytoplasm; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0002102; C:podosome; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0035033; F:histone deacetylase regulator activity; ISO:RGD.
DR   GO; GO:0004705; F:JUN kinase activity; IDA:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0019894; F:kinesin binding; IPI:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0120283; F:protein serine/threonine kinase binding; ISO:RGD.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; ISO:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IEP:RGD.
DR   GO; GO:0071276; P:cellular response to cadmium ion; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0071732; P:cellular response to nitric oxide; ISO:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0090650; P:cellular response to oxygen-glucose deprivation; IMP:RGD.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISO:RGD.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0097009; P:energy homeostasis; ISO:RGD.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEP:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISS:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0048666; P:neuron development; IEP:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IMP:MGI.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:RGD.
DR   GO; GO:2000017; P:positive regulation of determination of dorsal identity; ISO:RGD.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0034352; P:positive regulation of glial cell apoptotic process; IMP:RGD.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IMP:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:2001224; P:positive regulation of neuron migration; IMP:RGD.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; ISO:RGD.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0097300; P:programmed necrotic cell death; ISO:RGD.
DR   GO; GO:0061833; P:protein localization to tricellular tight junction; ISO:RGD.
DR   GO; GO:0046605; P:regulation of centrosome cycle; IMP:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:1904809; P:regulation of dense core granule transport; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:0032880; P:regulation of protein localization; ISO:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; ISO:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0009411; P:response to UV; ISO:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IMP:RGD.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; ISO:RGD.
DR   GO; GO:0097050; P:type B pancreatic cell apoptotic process; IMP:CACAO.
DR   CDD; cd07850; STKc_JNK; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR050117; MAP_kinase.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR008351; MAPK_JNK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24055; MITOGEN-ACTIVATED PROTEIN KINASE; 1.
DR   PANTHER; PTHR24055:SF222; MITOGEN-ACTIVATED PROTEIN KINASE 8; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01772; JNKMAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Biological rhythms; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; S-nitrosylation;
KW   Serine/threonine-protein kinase; Synapse; Transferase.
FT   CHAIN           1..411
FT                   /note="Mitogen-activated protein kinase 8"
FT                   /id="PRO_0000186264"
FT   DOMAIN          26..321
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          368..411
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           183..185
FT                   /note="TXY"
FT   COMPBIAS        386..411
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        151
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         32..40
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         55
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         116
FT                   /note="S-nitrosocysteine; in inhibited form"
FT                   /evidence="ECO:0000269|PubMed:11121042"
FT   MOD_RES         183
FT                   /note="Phosphothreonine; by MAP2K7"
FT                   /evidence="ECO:0000250|UniProtKB:P45983"
FT   MOD_RES         185
FT                   /note="Phosphotyrosine; by MAP2K4"
FT                   /evidence="ECO:0000250|UniProtKB:P45983"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Y86"
FT   MUTAGEN         116
FT                   /note="C->S: Abolished inhibitory effect of IFN-gamma on
FT                   JNK1 activity."
FT                   /evidence="ECO:0000269|PubMed:11121042"
SQ   SEQUENCE   411 AA;  46807 MW;  04E388B4F94633D4 CRC64;
     MSRSKRDNNF YSVEIADSTF TVLKRYQNLK PIGSGAQGIV CAAYDAILER NVAIKKLSRP
     FQNQTHAKRA YRELVLMKCV NHKNIIGLLN VFTPQKSLEE FQDVYIVMEL MDANLCQVIQ
     MELDHERMSY LLYQMLCGIK HLHSAGIIHR DLKPSNIVVK SDCTLKILDF GLARTAGTSF
     MMTPYVVTRY YRAPEVILGM GYKENVDLWS VGCIMGEMVC LKILFPGRDY IDQWNKVIEQ
     LGTPCPEFMK KLQPTVRTYV ENRPKYAGYS FEKLFPDVLF PADSEHNKLK ASQARDLLSK
     MLVIDASKRI SVDEALQHPY INVWYDPSEA EAPPPKIPDK QLDEREHTIE EWKELIYKEV
     MDLEERTKNG VIRGQPSPLG AAVINGSQHP VSSPSVNDMS SMSTDPTLAS D
//
